Orion Oyj

Country
Finland
Sector
Healthcare
Industry
Drug Manufacturers - General
Employees
3,657
Ticker
ORNBV
Exchange
NASDAQ HELSINKI LTD
Description
Orion Oyj is a leading Finnish pharmaceutical company that plays a significant role in the development and manufacturing of a broad range of medical products. Its primary function is to innovate and p...

Orion Oyj's Financial Statements Preview

Below are the financial statements of Orion Oyj, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

Interested in getting early access to our real-time standardized financial datafeed?
Learn More
All figures in millions of EUR
2024
2023
Net sales
1,542.4a
1,189.7a
Cost of goods sold
-596a
-531.9a
Gross profit
946.4a
657.7a
Other operating income and expenses
9.5a
43.7a
Selling and marketing expenses
-278.1a
-224.8a
Research and development expenses
-179.6a
-126.9a
Administrative expenses
-81.7a
-74.8a
Operating profit
416.6a
274.9a
Finance income and expenses
-3.5a
-3a
Profit before taxes
413.1a
271.9a
Income tax expense
-83.2a
-55.1a
Profit for the period
329.9a
216.8a
Profit attributable to
Owners of the parent company
329.9a
216.8a
Download Data

Verified Sources Behind Orion Oyj’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Orion Oyj’s data sources below and access millions more through our Disclosure Search.

a. Orion Oyj's Annual Report 2024
a. Orion Oyj's Annual Report 2024
Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

Tracenable is building real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?